PharmacoEconomics & Outcomes News Weekly


ISSN: 1173-5503        年代:2003
当前卷期:Volume &NA;  issue 411     [ 查看所有卷期 ]

年代:2003
 
     Volume 421  issue &NA;   
     Volume &NA;  issue 394   
     Volume &NA;  issue 395   
     Volume &NA;  issue 396/397   
     Volume &NA;  issue 398   
     Volume &NA;  issue 399   
     Volume &NA;  issue 400   
     Volume &NA;  issue 401   
     Volume &NA;  issue 402   
     Volume &NA;  issue 403   
     Volume &NA;  issue 404   
     Volume &NA;  issue 405   
     Volume &NA;  issue 406   
     Volume &NA;  issue 407   
     Volume &NA;  issue 408/09   
     Volume &NA;  issue 410   
     Volume &NA;  issue 411
     Volume &NA;  issue 412   
     Volume &NA;  issue 413   
     Volume &NA;  issue 414   
     Volume &NA;  issue 415   
     Volume &NA;  issue 416   
     Volume &NA;  issue 417   
     Volume &NA;  issue 418   
     Volume &NA;  issue 419   
     Volume &NA;  issue 420   
     Volume &NA;  issue 422   
     Volume &NA;  issue 423   
     Volume &NA;  issue 424   
     Volume &NA;  issue 425   
     Volume &NA;  issue 426   
     Volume &NA;  issue 427   
     Volume &NA;  issue 428   
     Volume &NA;  issue 429   
     Volume &NA;  issue 430   
     Volume &NA;  issue 431   
     Volume &NA;  issue 432   
     Volume &NA;  issue 433   
     Volume &NA;  issue 434   
     Volume &NA;  issue 435   
     Volume &NA;  issue 436   
     Volume &NA;  issue 437   
     Volume &NA;  issue 438   
     Volume &NA;  issue 439   
     Volume &NA;  issue 440   
     Volume &NA;  issue 441   
     Volume &NA;  issue 442   
     Volume &NA;  issue 443   
1. Is central stimulant use for ADHD heading in the right direction?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  2-2

&NA;,  

Preview

2. The US CDC's*Advisory Committee on Immunization Practices (ACIP) has released updated recommendations for the prevention and control of influenza.
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  3-3

&NA;,  

Preview

3. Cognitive therapy worth it to prevent relapse in depression?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  4-4

&NA;,  

Preview

4. Nasal airway treatment worth it in sleep apnoea syndrome?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  5-5

&NA;,  

Preview

5. Medicine use high among children and adolescents worldwide
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  6-6

&NA;,  

Preview

6. Modest BP changes greatly affect CV risk, cost burden in OA, RA
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  7-7

&NA;,  

Preview

7. Lithium to valproic acid prescribing shift in the elderly lacks evidence
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  8-8

&NA;,  

Preview

8. Barriers to ADHD diagnosis, treatment in ethnic minorities in the US
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  9-9

&NA;,  

Preview

9. Fibrin glue for GI bleeding: worth the extra cost?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  10-10

&NA;,  

Preview

10. To limit the use of oral leukotriene antagonists for allergic rhinitis, such prescriptions will require prior authorisation in the US Massachusetts Medicaid programme, effective from 2 June this year,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  411,   2003,   Page  11-11

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共11条